Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone [11]

Leukemia

Volumn 18, Issue 9, 2004, Pages 1561-1562

  Novoselac, A V ^a   Reddy, S ^a   Sanmugarajah, J ^a  

^a LENOX HILL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CORTICOSTEROID; DAUNORUBICIN; IDARUBICIN; MITOXANTRONE; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; ANTINEOPLASTIC AGENT;

ADULT; BLOOD EXAMINATION; BLOOD SMEAR; BONE MARROW BIOPSY; BONE MARROW EXAMINATION; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GRAM NEGATIVE INFECTION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LETTER; LEUKEMIA REMISSION; MUCOSA INFLAMMATION; MULTIPLE SCLEROSIS; OUTPATIENT CARE; PANCYTOPENIA; PRIORITY JOURNAL; PROMYELOCYTE; PROMYELOCYTIC LEUKEMIA; SEPTICEMIA; CHEMICALLY INDUCED DISORDER; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MITOXANTRONE; MULTIPLE SCLEROSIS; TREATMENT OUTCOME;

EID: 4444233652     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403417     Document Type: Letter

References (8)

1. Beaumont M, Sanz M, Carli PM, Maloisel F, Thomas X, Detourmignies L et al. Therapy related acute promyelocytic leukemia. J Clin Oncol 2003; 21: 2123-2137.
2. Pedersen-Bjergaard J, Andersen MK, Christiansen DH, Nerlov C. Genetic pathways in therapy related myelodysplasia and acute myeloid leukemia. Blood 2002; 99: 1909-1912.
3. Andersen MK, Larson RA, Mauritzson N, Schnittger S, Jhanwar SC, Pedersen-Bjergaard J. Balanced chromosomal abnormalities inv(16) and t(15,17) in therapy related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 2002; 33: 395-400.
4. Polman CH, Uitdehaag BM. New and emerging treatment options for multiple sclerosis. Lancet Neurol 2003; 2: 563-566.
5. Ghalie RG, Mauch E, Edan G, Hartung HP, Gonsette RE, Eisenmann S et al. A study of therapy related acute leukemia after mitoxantrone therapy for multiple sclerosis. Mult Scler 2002; 8: 441-445.
6. Vicari AM, Ciceri F, Folli F, Lanzi R, Colombo B, Comi G et al. Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis. Leukemia 1998; 12: 441-442.
7. Cattaneo C, Almici C, Borlenghi E, Motta M, Rossi G. A case of acute promyelocytic leukemia following mitoxantrone treatment of multiple sclerosis. Leukemia 2003; 17: 986-987.
8. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C et al. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood 1997; 90: 1014-1021.